Telos Corporation
NASDAQ:TLSInformation Technology Services
-$0.01 today
- Market cap
- $544.88M
- Beta
- 0.97
- P/E (TTM)
- -12.4
- EPS (TTM)
- -$0.35
Volume 0.84M
Average 0.87M
TLS Interest Expense
Cost of servicing the company's debt during the period.
Telos CorporationNASDAQ: TLS
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense declines year over year
Q1 FY2026 interest expense of $111K fell 24.5% year over year, behind the -16.1% change in trailing-twelve-month interest expense. Sequentially, it fell 14.0% from the prior quarter. Over 3 fiscal years it compounded at -14.2% a year.
Context
- Interest expense amounted to 0.3% of revenue in FY2025, down 0.3 pp from a year earlier.
- Interest expense increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -24.5% toward the trailing-twelve-month pace of -16.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 553K USD
- Year-over-year change
- -14.1%
- 4-year CAGR
- -8.2%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 553K | -14.1% |
| FY2024 | 2024-12-31 | 644K | -18.1% |
| FY2023 | 2023-12-31 | 786K | -10.1% |
| FY2022 | 2022-12-31 | 874K | +12.5% |
| FY2021 | 2021-12-31 | 777K | — |
Interest Expense vs competitors
How TLS compares with its peers on the latest reported figures
- Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -16.1% is the 6th highest of 8, against a peer median of -2.1%.
- Interest expense amounts to 0.3% of revenue for TLS, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $299M USD | +137.3% | +39.7% | 4.0% | |
| LTM Mar 2026 | $136.59M USD | -2.1% | +2.5% | 7.8% | |
| LTM Mar 2026 | $7.26M USD | -41.1% | -10.8% | 2.4% | |
| LTM Mar 2026 | $3.88M USD | +8.1% | +66.7% | 1.9% | |
| LTM Mar 2026 | $2.21M USD | +15.3% | -12.7% | 0.3% | |
| LTM Mar 2026 | $1.16M USD | -14.6% | +8.2% | 0.2% | |
| LTM Mar 2026 | $517K USD | -16.1% | -14.2% | 0.3% | |
| LTM Mar 2026 | $506K USD | -61.8% | +128.4% | 0.2% | |
| LTM Mar 2026 | $19K USD | — | — | 0.0% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥0 CNY | — | — | — |
| Peer median (excluding TLS) | — | -2.1% | +8.2% | 1.1% | |
Competitors are the stored peer set for TLS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 242.43M | 216.89M | 145.38M | 108.27M | 164.81M |
| Cost of Revenue | 156.4M | 137.84M | 92.44M | 73.84M | 103.79M |
| Gross Profit | 86.03M | 79.04M | 52.94M | 34.43M | 61.02M |
| Gross Margin | 35.5% | 36.4% | 36.4% | 31.8% | 37.0% |
| Research & Development | 19.1M | 16.92M | 12.25M | 8.44M | 7.06M |
| Selling, General & Admin | 108.4M | 115.98M | 81.01M | 75.49M | 78.93M |
| Operating Expenses | 127.49M | 132.89M | 93.26M | 90.3M | 85.53M |
| Depreciation & Amortization | 5.62M | 5.89M | 9.43M | 11.87M | 11.45M |
| EBITDA | (36.76M) | (46.61M) | (24.17M) | (39.98M) | (25.21M) |
| EBITDA Margin | -15.2% | -21.5% | -16.6% | -36.9% | -15.3% |
| Operating Income | (41.46M) | (53.85M) | (40.32M) | (55.87M) | (24.47M) |
| Operating Margin | -17.1% | -24.8% | -27.7% | -51.6% | -14.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 777K | 874K | 786K | 644K | 553K |
| Other Income / Expenses | (1.7M) | 476K | 5.93M | 3.38M | (12.74M) |
| Income Before Tax | (43.16M) | (53.37M) | (34.39M) | (52.49M) | (37.21M) |
| Pre-Tax Margin | -17.8% | -24.6% | -23.7% | -48.5% | -22.6% |
| Income Tax Expense | (28K) | 54K | 36K | 26K | (663K) |
| Net Income | (43.13M) | (53.43M) | (34.42M) | (52.52M) | (36.55M) |
| Net Margin | -17.8% | -24.6% | -23.7% | -48.5% | -22.2% |
| EPS (Basic) | (0.65) | (0.79) | (0.50) | (0.73) | (0.50) |
| EPS (Diluted) | (0.65) | (0.79) | (0.50) | (0.73) | (0.50) |
| Weighted Avg Shares | 66.37M | 67.56M | 69.26M | 71.85M | 72.88M |
| Weighted Avg Shares (Diluted) | 66.37M | 67.56M | 69.26M | 71.85M | 72.88M |
Telos Corporation
NASDAQ:TLS
Intrinsic Alpha fair value
Locked
Current Price
$7.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.